Cardioneuroablation for reflex syncope and functional bradycardia
Cardioneuroablation (CNA) is emerging as an interventional approach for selected patients with recurrent reflex syncope, vagally mediated pauses, and functional bradycardia. The procedure uses catheter ablation to modify cardiac autonomic inputs, particularly parasympathetic activity conveyed through ganglionated plexi. Its aim is to reduce inappropriate cardioinhibition while preserving appropriate autonomic regulation.
This strategy addresses a clinically important gap. Conventional management may include education, hydration, physical counter-pressure maneuvers, medication review, and, in carefully selected cases, permanent pacing. Pacing can prevent pauses, but it does not correct vasodilation or the broader reflex mechanism. CNA seeks to treat the neural component of the response, although patient selection and procedural endpoints remain central to safe practice.
Evidence is expanding through observational studies, prospective cohorts, and small randomized comparisons. Interpretation requires attention to the phenotype being treated: a patient with documented asystolic reflex syncope is different from one with unexplained sinus bradycardia, intrinsic conduction disease, or hypotension without a significant cardioinhibitory component.
Why autonomic modulation is being considered
Reflex syncope results from an inappropriate cardiovascular response to a trigger or prodrome. Increased vagal discharge can slow sinus node activity or impair atrioventricular conduction, while sympathetic withdrawal can lower vascular tone. The resulting combination of bradycardia, pauses, and hypotension may cause transient loss of consciousness. In some patients, the dominant feature is cardioinhibition; in others, vasodepression is the principal mechanism.
Ganglionated plexi contain complex networks of autonomic neurons located around the atria, pulmonary veins, interatrial septum, superior vena cava, and other structures. Parasympathetic stimulation of these networks can produce sinus slowing or atrioventricular block. By applying radiofrequency energy, or in selected settings another energy source, operators attempt to reduce excessive vagal influence on the sinus and atrioventricular nodes.
The term functional bradycardia is important. It generally describes slowing caused by autonomic imbalance rather than irreversible disease of the conduction system. CNA is therefore conceptually different from ablation for atrial fibrillation and from treatment of degenerative sinus node dysfunction. If intrinsic conduction disease is present, autonomic denervation may provide little benefit and could delay a more appropriate pacing strategy.
Selecting patients with a cardioinhibitory phenotype
The strongest rationale exists in patients with recurrent, severe, unpredictable syncope and objective evidence of a cardioinhibitory reflex. Documentation may come from an implantable loop recorder, tilt-table testing, carotid sinus assessment when appropriate, or telemetry obtained during a spontaneous event. Findings can include prolonged asystole, profound sinus bradycardia, or transient atrioventricular block associated with symptoms.
Clinical history remains indispensable. Prodromes, posture, triggers, recovery pattern, injury, family history, medication exposure, and coexisting structural heart disease help distinguish reflex syncope from ventricular arrhythmia, orthostatic hypotension, epilepsy, and intrinsic bradyarrhythmia. A positive tilt-table test may support a diagnosis, but it does not always predict the degree of benefit from CNA because the test may reproduce a mixed vasodepressor and cardioinhibitory response.
Age, comorbidity, and treatment preferences also influence decisions. Younger patients with frequent episodes may wish to avoid lifelong device implantation, while older patients with conduction disease may derive more reliable protection from pacing. Patients should understand that autonomic ablation may reduce pauses without eliminating hypotension, prodromes, or future syncope.
How the procedure is performed and assessed
CNA is usually performed during an electrophysiology study with three-dimensional electroanatomical mapping. Target regions are selected according to anatomical location, local electrogram characteristics, fractionated signals, and responses to high-frequency stimulation or pharmacological autonomic testing. Commonly assessed areas include the right and left atrial ganglionated plexi, the superior vena cava–right atrial region, and the interatrial septal area near the atrioventricular node.
There is no universally accepted procedural endpoint. Operators may evaluate changes in sinus rate, atrioventricular conduction, corrected sinus node recovery time, or the response to atropine. A reduction in vagal response can indicate denervation, but an immediate electrophysiological change does not guarantee durable clinical benefit. Autonomic reinnervation may occur, and the relationship between acute endpoints and long-term symptom control is still being defined.
Energy delivery must be balanced carefully. Excessive ablation near the atrioventricular node can cause permanent conduction injury, while incomplete lesion formation may produce an inadequate effect. Standard procedural safeguards include intracardiac imaging when needed, anticoagulation according to the left- or right-sided approach, careful catheter stability, and post-procedure rhythm monitoring.
Evidence, limitations, and unanswered questions
Reports of CNA for vasovagal syncope and functional sinus node dysfunction commonly describe reductions in syncope recurrence and improvements in resting or exertional heart rate. Some studies have also reported fewer pauses and reduced dependence on temporary or planned pacing. These findings are encouraging, but many investigations are single-center, non-randomized, and vulnerable to selection bias, regression to the mean, and changes in patient behavior after enrollment.
Comparisons with permanent pacing are especially complex. A pacemaker directly prevents clinically significant bradycardia, whereas CNA targets the autonomic trigger and may leave vasodepression untreated. The most meaningful comparison may therefore involve carefully selected subgroups rather than all patients with reflex syncope. Long-term follow-up is needed to determine whether symptom reduction remains durable when autonomic pathways recover.
For readers following developments in autonomic ablation, the journal’s special issues can provide a useful route to themed discussions of electrophysiology, syncope, and device-based care. Future research should standardize definitions of cardioinhibitory syncope, procedural mapping, acute endpoints, quality-of-life measures, and follow-up duration. Studies should also report complications, repeat procedures, pacemaker implantation after CNA, and recurrent hypotension rather than focusing solely on syncope-free survival.
| Clinical feature | CNA may be considered | Alternative or additional focus |
|---|---|---|
| Recurrent, severe syncope with documented pauses | Stronger rationale for autonomic modulation | Compare with pacing according to age, risk, and preference |
| Positive tilt test with mixed hypotension and bradycardia | Potential benefit, but response may be incomplete | Treat orthostatic and vasodepressor mechanisms |
| Isolated resting sinus bradycardia without syncope | Limited indication | Evaluate medications, fitness, sleep, and intrinsic sinus disease |
| Established His–Purkinje or degenerative conduction disease | Usually poor fit for CNA alone | Permanent pacing assessment |
| Infrequent, predictable vasovagal episodes | Invasive therapy may be disproportionate | Education, trigger avoidance, hydration, and counter-pressure maneuvers |
| Recurrent symptoms after CNA | Reassess mechanism and autonomic recovery | Repeat testing, medication review, or pacing when indicated |
Integrating CNA into clinical decision-making
Before referral, clinicians should confirm that the episodes are likely arrhythmic or reflex in origin and that reversible contributors have been addressed. Drugs that lower heart rate or blood pressure deserve review, as do dehydration, anemia, endocrine disorders, sleep-disordered breathing, and autonomic neuropathy. A detailed event record can be more informative than a single office electrocardiogram.
The procedural discussion should cover uncertainty as clearly as potential benefit. Patients need to know that CNA does not guarantee freedom from syncope, may not correct vasodilation, and can produce complications including vascular injury, pericardial effusion, thromboembolism, atrial arrhythmia, phrenic nerve injury in relevant locations, or unintended conduction damage. The possibility of later pacemaker implantation should remain part of informed consent.
Post-procedure assessment can include symptom diaries, ambulatory monitoring, orthostatic vital signs, exercise evaluation, and repeat autonomic testing when clinically justified. Follow-up should examine both recurrence and new symptoms, including inappropriate sinus tachycardia or palpitations. An increased resting heart rate may be expected after vagal modification, but persistent tachyarrhythmia requires separate evaluation.
Building a research-informed practice
The field benefits from collaboration between syncope specialists, electrophysiologists, autonomic laboratories, and device experts. Consistent terminology is particularly important because “cardioneuroablation” may describe different lesion sets, mapping methods, and endpoint definitions across institutions. Reports should identify whether the treated phenotype was sinus arrest, atrioventricular block, mixed reflex syncope, or presumed functional sinus node dysfunction.
Education also matters for trainees and clinicians who encounter unexplained fainting outside specialist centers. Peer-reviewed arrhythmia collections can help place CNA within the wider evidence base that includes implantable monitoring, pacing, ablation, pharmacology, and autonomic testing. A broad perspective reduces the risk of presenting CNA as a universal substitute for established treatments.
Practical research priorities include randomized trials with clinically meaningful follow-up, validated quality-of-life instruments, blinded adjudication of syncope, and systematic assessment of blood pressure responses. Patient-reported prodrome, injury prevention, work limitations, and treatment burden should accompany rhythm outcomes. These measures will clarify which patients gain a durable advantage from autonomic modulation.
Practical recommendations for clinicians
- Confirm a reproducible reflex or functional bradycardia phenotype before considering an invasive procedure.
- Document symptom–rhythm correlation whenever feasible, using prolonged monitoring when routine testing is unrevealing.
- Distinguish cardioinhibition from vasodepression and address orthostatic, medication-related, and metabolic contributors.
- Discuss CNA, pacing, conservative care, and ongoing uncertainty through shared decision-making.
- Use experienced electrophysiology teams with structured procedural endpoints and long-term follow-up.
CNA represents a promising shift from treating the final pause to modifying the autonomic pathway that produces it. Its role is best defined through disciplined diagnosis, transparent counseling, and evidence that separates functional bradycardia from intrinsic conduction disease. Clinicians and researchers can advance the field by applying consistent methods, reporting durable outcomes, and matching each patient to the least burdensome treatment that offers meaningful protection. Explore the developing literature through Journal of Arrhythmia’s research and educational resources, and apply emerging evidence thoughtfully in syncope and rhythm practice.